-
681
Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
Published 2023-07-01Subjects: “…Drug-interactions…”
Get full text
Article -
682
-
683
-
684
Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3
Published 2023-06-01Subjects: Get full text
Article -
685
-
686
-
687
-
688
Interações medicamentosas em prescrições de idosos hipertensos: prevalência e significância clínica [Drug interactions in prescriptions for elderly hypertensive patients: prevalence and clinical significance]
Published 2015-03-01Subjects: “…atenção primária à saúde [drug interactions…”
Get full text
Article -
689
-
690
-
691
Simultaneous Pharmacokinetic Evaluation of Pantoprazole and Vitamin B Complex for Assessing Drug–Drug Interactions in Healthy Bangladeshi Adults by a Newly Developed and Validated HPLC Method
Published 2023-03-01Subjects: “…drug interactions…”
Get full text
Article -
692
-
693
-
694
-
695
-
696
-
697
A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators
Published 2021-05-01Subjects: “…drug–drug interaction (DDI)…”
Get full text
Article -
698
Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling
Published 2023-04-01“…A tiered approach was applied to understand the CYP3A victim and perpetrator drug–drug interaction (DDI) potential for vonoprazan. Mechanistic static modeling suggested vonoprazan is a potential clinically relevant CYP3A inhibitor. …”
Get full text
Article -
699
A comprehensive evaluation in clinic and physiologically‐based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450–mediated drug–drug interaction potential for pomotrelvir
Published 2023-10-01“…Here the cytochrome P450 (CYP)–mediated drug–drug interaction (DDI) potential of pomotrelvir was evaluated for major CYP isoforms, starting with in vitro assays followed by the basic static model assessment. …”
Get full text
Article -
700
Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence?
Published 2023-12-01“…Plasma levels measurements confirm that CNB acts both as “victim” and as “perpetrator” of drug-drug interactions.…”
Get full text
Article